The University of Birmingham has received £2.2m in government funding to improve the treatment, causes and symptoms of so-called Long COVID in non-hospitalised patients.
Posted 23 July 2021 Longer interval between the first and second Pfizer vaccine boosts antibody levels and 'helper' T cells A new study carried out in collaboration with the University of Birmingham shows both short and long dosing schedules of the Pfizer COVID-19 vaccine generate strong antibody and T cell immune responses.
Posted 23 July 2021 People with five or more symptoms in first week of infection more likely to develop long COVID The presence of more than five symptoms of COVID-19 in the first week of infection is significantly associated with the development of long COVID.
Posted 09 July 2021 COVID:19: Scientists condemn government's 'dangerous & unethical COVID-19 experiment' University of Birmingham scientists are among more than 100 experts who have signed a letter published in The Lancet urging the UK Government to reconsider its plans to abandon all COVID-19 restrictions.